| Literature DB >> 35068896 |
Abstract
BACKGROUND: Methimazole is an antithyroid drug. It has side effects on many tissues. Bone marrow-derived mesenchymal stem cells (BM-MSCs) are promising in the field of tissue regeneration.Entities:
Keywords: BM-MSC; BM-MSCs, bone marrow mesenchymal stem cells; Dentin Regeneration; H&E, hematoxylin and eosin; Methimazole; P-value, probability value; SD, standard deviation; β-catenin
Year: 2021 PMID: 35068896 PMCID: PMC8767165 DOI: 10.1016/j.sdentj.2021.09.019
Source DB: PubMed Journal: Saudi Dent J ISSN: 1013-9052
Fig. 1H&E-stained sections: (a)- Group I showing: continuous layer of tall columnar odontoblasts with basal oval nuclei (A). Definite apparently wide layer of predentin (B). Dentin with well-defined parallel dentinal tubules (C) and intertubular dentin (D). (b)- Group II showing: discontinued odontoblastic layer (A). Some detached and desquamated odontoblasts (B). Most of odontoblasts apparently lose their cell height and appear shrunken (C). Some cells have pyknotic and hyperchromatic nuclei (D). Obviously very narrow, discontinued and ill-defined layer of predentin (E). Dentin with ill-defined dentinal tubules and intertubular dentin (F) as well as areas of different stainability (G). (c)- Group III showing: perceptibly wide layer of pre-odontoblasts (A). Continuous evidently wide layer of apparently numerous odontoblast-like cells with some cells have tall columnar shape and basally located oval nuclei (B) while others are cuboidal (C). Ostensibly narrow but well-defined continuous layer of predentin (D). Distinct dentinal tubules (E) and intertubular dentin (F). (d)- Group IV showing: pre-odontoblastic layer (A). Incessant layer of tall columnar odontoblast-like cells with basal oval nuclei (B). Allegedly wide, continuous and distinct predentin layer (C). Well-demarcated parallel dentinal tubules (D) and intertubular dentin (E), (x400).
Fig. 2Masson's trichrome-stained sections: (a)- Group I showing: dentin with some areas of newly formed collagen (A) and apparently equivalent areas of old collagen (B). (b)- Group II showing: mainly old collagen in dentin (A). New collagen in evidently very narrow predentin layer (B) and peritubular dentin in perceptibly few dentinal tubules (C). (c)- Group III showing: only newly formed collagen in dentin (A). (d)- Group IV showing: some areas of newly formed collagen (A) and apparently equivalent areas of old collagen (B) in dentin, (x400).
Fig. 3β-catenin-stained sections of studied groups, displaying different immunoreactivity patterns in dentin (A), different patterns of nuclear and cytoplasmic immunoreactivity in odontoblasts (B) and odontoblast-like cells (C). (a)- Group I presenting: strong immunoreactivity. (b)- Group II exhibiting: mild immunoreactivity. (c)- Group III revealing: moderate immunoreactivity. (d)- Group IV illustrating: strong immunoreactivity, (x400).
Displaying the range values, mean ± SD, ANOVA and Least Significant Difference post hoc results of newly formed collagen area% in different studied groups.
| Mean±SD | 44.62±0.09 | 2.91±0.08a | 96.99±0.08ab | 42.60±0.09abc | 224.669 | <0.001** |
| Range | 44.5–44.7 | 2.8–3 | 96.9–97.1 | 42.5–42.7 |
Superscript letters according to Least Significant Difference post hoc test designate; a: significant difference versus Group I; b: significant difference versus Group II; c: significant difference versus Group III.
**: High significance at p-value < 0.001
Fig. 4(a)- Bar chart showing values of means and SD for newly formed collagen area% in all studied groups. *P < 0.05, **P < 0.001 (b)- Bar chart displaying values of means and SD for β-catenin-immunoreactivity area% in all studied groups. **P < 0.001.
Presenting the range values, mean ± SD, ANOVA and Least Significant Difference post hoc results of β-catenin-immunoreactivity area% in different studied groups.
| Mean±SD | 97.91±0.07 | 22.91±0.08a | 48.61±0.08ab | 95.51±0.09abc | 116.397 | <0.001** |
| Range | 97.8–98 | 22.8–23 | 48.5–48.7 | 95.4–95.6 |
Superscript letters according to Least Significant Difference post hoc test designate; a: significant difference versus Group I; b: significant difference versus Group II; c: significant difference versus Group III.
**: High significance at p-value < 0.001.